Braze (NASDAQ:BRZE) stock fell 12% to $26.58 early Wednesday after the company's fiscal third-quarter adjusted EPS guidance of $0.13 to $0.14 came in below analysts' models, despite beating Q2 expectations with revenue up 26.2% year-over-year to $227.23 million and non-GAAP EPS of $0.19 (vs. consensus $0.16). Meanwhile, peer Klaviyo (NYSE:KVYO) stock advanced 3% to $18.42, notably refusing to sell off in sympathy.